KR

Kurre Ramachandra Reddy

Director DIN 00628293
DIN 00628293 First appointment Jul 2006
Unlock full profile Investments Β· shareholding Β· contact details
Past companies 2 historical roles
Total affiliations 2 Since Jul 2006
Shareholding value β€’β€’β€’β€’ Premium profile

About Kurre Ramachandra Reddy

Data last updated:

Kurre Ramachandra Reddy was a Director at Syntax Therapeutics Private Limited (from 2006) and Director at Serene Paints And Colors Private Limited (from 2009).

DIN 00628293
First Appointment 27 Jul 2006
Oldest Company Age 21 yrs

Previous companies

CompanyDesignationAppointmentFoundedRevenueStatus
Syntax Therapeutics Private Limited U24203TG2005PTC045902
Director27 Jul 20062005Strike Off
Director15 Dec 20092009₹57.2 Lakh (FY 2017)Strike Off

Explore Director's current and past company associations Uncover their professional journey today!

Directorship timeline

Open interactive timeline →
Syntax Therapeutics Private Limited
Serene Paints And Colors Private Limited
Premium access

Shareholding and investment profile for Kurre Ramachandra Reddy

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Kurre Ramachandra Reddy

Kurre Ramachandra Reddy was first appointed on 27 Jul 2006 as Director at Syntax Therapeutics Private Limited. The most recent appointment on record is 15 Dec 2009 at Serene Paints And Colors Private Limited.

Kurre Ramachandra Reddy held 2 earlier board appointments: Syntax Therapeutics Private Limited (Director, from 27 Jul 2006); Serene Paints And Colors Private Limited (Director, from 15 Dec 2009).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available